$3.1m Multiyear Contract with leading US Insurer

Cirata

13/10/2025 07:00

RNS Number : 0038D

Cirata PLC

13 October 2025

 

13 October 2025

Cirata plc

("Cirata" or the "Company")

$3.1m Multiyear Data Integration Contract with leading US Insurer  

The largest direct contract in Company's history

Cirata plc (LSE: CRTA) is pleased to announce a $3.1m, 3-year Data Integration (DI) software contract with a leading US insurer. This growth contract represents the largest direct contract in Cirata's history and signifies a transition from a 1-year legacy Fusion product agreement to a new longer term 3-year partnership and relationship.

 

The new contract encompasses the deployment of Data Migrator (DM), with a focus on disaster recovery applications.

 

Cirata expects to provide a Q3 FY25 Trading Update on 16 October 2025.

 

This announcement contains inside information under the UK Market Abuse Regulation. The person responsible for arranging the release of this announcement on behalf of Cirata plc is Stephen Kelly, Chief Executive Officer.

 

For further information, please contact: 

Cirata
Via FTI Consulting
Stephen Kelly, Chief Executive Officer
Ricardo Moura, Chief Financial Officer
Dan Hayes, Investor Relations
FTI Consulting
+44 (0) 20 3727 1137
Matt Dixon / Kwaku Aning / Usama Ali
Stifel (Nomad and Joint Broker)
+44 (0) 20 7710 7600
Fred Walsh / Brough Ransom / Ben Good
Panmure Liberum (Joint Broker)
+44 (0) 20 3100 2000
Max Jones / Rupert Dearden / John More


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
CNTMBBMTMTMBBFA